SOURCE: Feelgoods International, Inc.

October 09, 2006 08:31 ET

Feelgoods International, Inc. Enters Three Billion Dollar Nutriceuticals Market in Germany

Opens New Office in Germany and Announces Michael Heinricks as Vice President of Business Development

ZURICH-KLOTEN, SWITZERLAND -- (MARKET WIRE) -- October 9, 2006 -- Feelgoods International, Inc. (PINKSHEETS: FGNL) is proud to announce that the Company is immediately opening a new Feelgoods International office in Kerken, Germany, near Dusseldorf. The German pharmaceutical market for nutriceuticals is currently estimated to be a three billion dollar industry and is continuously expanding.

Michael Heinricks will head up the new location as Vice President of Business Development in Germany. Mr. Heinricks has formerly specialized in business travel and travel management. Additionally, Mr. Heinricks has had several years of experience in the trade show organization and management fields, as well as the coaching and training of sales teams.

"This is a tremendously important step for our company and it bodes well for the future of our Feelgoods franchise strategy. The German office, under Mr. Heinricks' leadership, will be a cornerstone for our Company to pursue and fulfill our business strategy which states that over the next five years we aim to acquire and open 300 health store franchisees within Germany," stated Marcel Maurer, CEO of Feelgoods International, Inc.

About Feelgoods International, Inc.:

Feelgoods International, Inc.: Based in Zurich-Kloten, Switzerland, Feelgoods International, Inc. (www.feelgoodsint.com) offers a unique franchise business opportunity for thousands of European Pharmacies. The franchise system is designed to significantly increase the pharmacy's revenue by maximizing the revenue potential of a Pharmacy's existing customer traffic. The Feelgoods model is easily incorporated into a Pharmacy's existing floor space, producing a self-contained business or "shop within a shop." Feelgoods' focus is on products that complement the pharmacy's conventional inventory by introducing products such as alternative medications, nutriceuticals, lifestyle products and bio cosmetics.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact Information